Ronald Bentsur
Algemeen Directeur bij NUVECTIS PHARMA, INC.
Vermogen: 21 M $ op 30-04-2024
Actieve functies van Ronald Bentsur
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NUVECTIS PHARMA, INC. | Algemeen Directeur | 27-07-2020 | - |
Voorzitter | 27-07-2020 | - | |
Oprichter | 27-07-2020 | - | |
President | 27-07-2020 | - | |
BEYOND AIR, INC. | Directeur/Bestuurslid | 01-08-2015 | - |
Independent Dir/Board Member | 01-08-2015 | - | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Directeur/Bestuurslid | 01-01-2017 | - |
Voorzitter | 01-08-2015 | 01-01-2017 | |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Voorzitter | 01-08-2015 | - |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Adviseur | - | - |
Loopbaan van Ronald Bentsur
Eerdere bekende functies van Ronald Bentsur
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
STEMLINE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2009 | 01-06-2020 |
UROGEN PHARMA LTD. | Directeur/Bestuurslid | 01-10-2015 | 03-01-2019 |
Algemeen Directeur | 01-08-2015 | 03-01-2019 | |
KERYX BIOPHARMACEUTICALS | Directeur/Bestuurslid | 16-06-2009 | 30-04-2015 |
Algemeen Directeur | 20-05-2009 | 30-04-2015 | |
XTL BIOPHARMACEUTICALS LTD. | Algemeen Directeur | 01-01-2006 | 01-04-2009 |
░░░░░ ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Ronald Bentsur
The Hebrew University of Jerusalem | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistieken
Internationaal
Israël | 8 |
Verenigde Staten | 7 |
Operationeel
Director/Board Member | 6 |
Chief Executive Officer | 4 |
Chairman | 3 |
Sectoraal
Health Technology | 10 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
XTL BIOPHARMACEUTICALS LTD. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
NEXTGEN BIOMED LTD | Health Technology |
NUVECTIS PHARMA, INC. | Health Technology |
BEYOND AIR, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Leumi Partners Underwriters Ltd. | |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
- Beurs
- Insiders
- Ronald Bentsur
- Ervaring